Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factor.
Environmental Pathology: SY09-2 MULTIPLE SCLEROSIS (MS) AND NEURODEGENERATION: CAUSE AND PATHOGENESIS IN RELATION TO ELECTROMAGNETIC FIELDS (EMF).
Potential role of 8-oxoguanine DNA glycosylase 1 as a STAT1 coactivator in endotoxin-induced inflammatory response.
Respiratory muscle training for respiratory deficits in neurodegenerative disorders: a systematic review.
Small-molecule Klotho enhancers as novel treatment of neurodegeneration.
Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis.
Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica.
Interferon Beta and vitamin d synergize to induce immunoregulatory receptors on peripheral blood monocytes of multiple sclerosis patients.
Orienting network dysfunction in progressive multiple sclerosis.
Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.
New and emerging immune-targeted drugs for the treatment of multiple sclerosis.
Association between the CD24 Ala57Val polymorphism and risk for multiple sclerosis and systemic lupus erythematosus: a meta-analysis.
Therapeutic inhibition of the alternative complement pathway attenuates chronic EAE.
Secondary hemophagocytic lymphohistiocytosis possibly induced by interferon beta-1a therapy.
Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.
Magnetic resonance outcome measures in multiple sclerosis trials: time to rethink?
The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.
The insulin-like growth factor system in multiple sclerosis.
Predictors of the physical impact of Multiple Sclerosis following community-based, exercise trial.
Clinical and Radiological Characteristics in Multiple Sclerosis Patients with Large Cavitary Lesions.
Reduced retinal nerve fiber layer thickness and macular volume in pediatric multiple sclerosis.
CNS neuroimmunology seen by a neuropathologist.
Health effects of lesion localization in multiple sclerosis: spatial registration and confounding adjustment.
Autoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis.
Melatonin Acts as Antioxidant and Improves Sleep in MS Patients.
Pages
« first
‹ previous
…
400
401
402
403
404
405
406
407
408
…
next ›
last »